SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond financing to fund its AI and data-center expansion is driving attention, with traders focused on dilution and rising debt. Bears view the raise as a sign of financial strain, while bulls argue it was part of a previously outlined funding plan and supports long-term growth.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is dominating discussion, with the fixed exchange ratio tying LITEs eventual value to Marvells share price until the deal closes. Many traders view the structure as unfavorable to Lumentum shareholders and are questioning the headline premium, while others see strategic value in combining Marvells connectivity business with Lumentums AI-optics technology.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreed all-stock acquisition of Lumentum is drawing attention as a major bet on optical connectivity for AI data centers. Traders are split: some see strategic value in combining Marvells chips with Lumentums optical technology, while others worry about dilution, the deals cost, and the muted market reaction.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Buzz centers on reports that POET optical engines were featured in Foxconns photonics ecosystem at Hon Hai Tech Day, renewing attention on its FIT partnership. Bulls see this as validation, while skeptics note that a demo does not confirm purchase orders or scaled shipments.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes quarterly results showed strong product-revenue growth and beat analyst expectations, yet the shares sold off sharply. Traders are debating whether the decline reflects the lack of quantified guidance and uncertainty around profitability and spending, or whether the Auvelity growthespecially its Alzheimers agitation launchis stronger than prescription trackers suggest.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluences CEO, CFO and customer-success chief are departing, with interim leaders appointed as the company seeks to address longstanding execution problems. Traders welcomed the shake-up as a possible reset, while skeptics argued that leadership changes alone wont fix manufacturing and delivery issues or restore confidence.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

A weak quarterly report and revenue miss have weighed on CIFR despite initial high-performance-computing lease revenue and progress on data-center contracts. Traders are divided between concerns about debt, dilution, and execution in the AI-infrastructure transition and confidence in the longer-term contracted lease opportunity.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about pressure on Precigens PAPZIMEOS. Traders debate whether the rivals dosing approach will erode demand or whether PAPZIMEOSs commercial head start, payer access, and full-approval status will help it retain an advantage.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CRMD is drawing attention after DaVitas preliminary outlook suggested DefenCaths reimbursement could decline through 2027, triggering a sharp selloff and renewed concern about the drugs adoption and revenue potential. Traders are divided: some see the comments and comparative ClearGuard data as a threat to DefenCaths economics, while others argue DaVitas estimate is uncertain and are buying the dip.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?

TECH's Q1 earnings are on deck, with revenues and EPS growth expected as investors weigh segment performance and the pending $11.3 billion acquisition.

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy DevelopmentPR NewswireMINNEAPOLIS, Oct. 8, 2026Investment...

Insider Activity Update: John L Higgins Executes Options Exercise, Resulting In $751K At Bio-Techne

On September 30, it was revealed in an SEC filing that John L Higgins, Director at Bio-Techne (NASDAQ:TECH) executed a significant exercise of company stock options.
What Happened: A Form 4 filing with the U.S.read more...

INCY or TECH: Which Is the Better Value Stock Right Now?

INCY vs. TECH: Which Stock Is the Better Value Option?

Robert V Baumgartner Exercises Options, Realizes $754K

Robert V Baumgartner, Board Member at Bio-Techne (NASDAQ:TECH), reported a large exercise of company stock options on September 24, according to a new SEC filing.
What Happened: In an insider options exercise disclosedread more...

Bio-Techne Shareholders Approve Merck KGaA Acquisition Plan

(RTTNews) - Wednesday, Bio-Techne Corp. (TECH) announced that its shareholders have approved the acquisition of the company by Merck KGaA (MKKGY.PK), Darmstadt, Germany, marking an important milestone toward completing the transaction...

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, GermanyPR NewswireMINNEAPOLIS, Sept. 23, 2026 MINNEAPOLIS, Sept. 23, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a...

Bio-Techne Opens New Customer Experience Center in Dsseldorf to Accelerate Scientific Discovery and Customer Collaboration

Bio-Techne Opens New Customer Experience Center in Dsseldorf to Accelerate Scientific Discovery and Customer Collaboration Bio-Techne Opens New Customer Experience Center in Dsseldorf to Accelerate Scientific Discovery and Customer CollaborationPR NewswireMINNEAPOLIS and DSSELDORF, Germany, Sept...

Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?

Techne (TECH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN PR Newswire NEW YORK, Sept. 10, 2026 NEW YORK, Sept. 10...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Bio-Techne Corp

Are AMZN Shares Poised For A 9-Day Losing Streak? Here’s What Retail Thinks

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>One bullish user on Stocktwits said they have not seen Amazon shares being this cheap on a price-to-earnings ratio in at least the last decade.&nbsp;</li><li>In its latest earnings results, Amazon said it would boost its capital expenditure for 2026 to $200 billion, up from about $130 billion reported in 2025.</li></ul>Amazon.com (AMZN) shares are poised for a ninth straight day of losses as concerns over the tech giant’s sharply higher capital spend planned for 2026 rise among investors.AMZN shares reversed to green, climbing 0.27% higher on Friday at the time of writing, after having declined about 0.7% earlier in the day.The stock has lost about 17.5% of its value in the last month, even as the company’s shares hover near their lowest level since May 23, 2025, when they opened at $198.90.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260213_095554045_png_8173413ba0.webp" alt="koyfin_20260213_095554045.png" width="2400" height="1240"><figcaption>Amazon Share Price | Source: Koyfin</figcaption></figure>On Stocktwits, retail sentiment around the stock has fallen in the past 24 hours, dropping from the ‘extremely bullish’ to ‘bullish’ territory at the time of writing. Meanwhile, retail chatter has jumped about 35% in the same period, according to Stocktwits data from Friday morning.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>One user on Stocktwits said that AMZN shares would trade higher after the soft January inflation report. The user said that lower rates were on the horizon on an ‘already completely over sold stock.’<stembedurl>https://stocktwits.com/Boardroommaster/message/644937046</stembedurl>&nbsp;Another bullish user said they have not seen Amazon shares being this cheap on a price-to-earnings ratio in at least the last decade.<stembedurl>https://stocktwits.com/America_First_Home_Loans/message/644917841</stembedurl>&nbsp;However, one user warned of more declines, including another dip next week, adding that the company would likely not breach $240 for another three to four months.<stembedurl>https://stocktwits.com/Snackdaddy/message/644876060</stembedurl>&nbsp;Another bullish user said that now would be the best time to buy a mega cap stock amid pullbacks, forecasting that AMZN shares would soar past $300 in the next six to 12 months.<stembedurl>https://stocktwits.com/What_Are_Stocks_2/message/644928956</stembedurl><h2 class="st-heading-2">&nbsp;</h2><h2 class="st-heading-2">Capital Spend</h2>In its latest <a href="https://stocktwits.com/news-articles/markets/equity/amazon-q4-2025-revenue-beats-estimates-on-strong-aws-results-announces-200b-capital-spending-in-2026/cZbZl9hR4n3">earnings results</a>, Amazon said it would boost its capital expenditure for 2026 to $200 billion, up from about $130 billion reported in 2025.This is in line with other large tech companies that have collectively announced plans to invest over $630 billion in AI buildouts in 2026, more than double the spend from 2025.Andy Jassy, President and CEO of Amazon, told investors that the capital expenditures would predominantly be in Amazon Web Services because of “very high demand,” adding that the company anticipated “strong long-term return on invested capital.”While investors have largely expressed concerns over the massive expenditures on AI by the tech companies, leaders have actively backed the plan. CEO of Nvidia Corp. (NVDA) Jensen Huang said earlier this month that these investments are “appropriate and sustainable,” noting that the demand for AI is now skyrocketing.Meanwhile, <a href="https://stocktwits.com/symbol/AMZN">shares of AMZN</a> have declined by over 13% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The logo and lettering of Amazon can be seen on the facade of Amazon Germany's headquarters in Parkstadt Schwabing in Munich (Bavaria). (Photo by Matthias Balk/picture alliance via Getty Images)

Amazon.com stock has lost about 17.5% of its value in the last one month, even as the company’s shares hover near their lowest level since May 23, 2025.

Roundhill Magnificent Seven ETF

Vanguard Consumer Discretionary ETF

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

TECH News